Craig M. Crews awarded the 2022 Connecticut Medal of Technology

Craig Crews is awarded for pioneering research that launched the pharmaceutical field of Targeted Protein Degradation (TPD). TPD is hailed as a new paradigm for drug development and will almost certainly lead to novel therapeutics. Described as an exceptionally creative scientist, with an eagerness to ask piercing, mechanism-based questions, and a commitment to evidence-based, first-rate, definitive science, he has had a profound translational impact in drug development.

Click here for the full story.